StonvexLoading…
StonvexStonvexStonvexCore line items from JBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $884.20M | $963.80M | $1.07B | $1.02B |
Operating Income | $111.50M | $146.60M | $245.70M | $187.50M |
Net Income | $53.80M | $70.40M | $135.70M | $107.70M |
EPS (Diluted) | $0.38 | $0.49 | $0.92 | $0.73 |
Total Assets | $1.30B | $1.30B | $1.35B | $1.27B |
Total Liabilities | $732.50M | $782.50M | $830.40M | $895.30M |
Cash & Equivalents | $194.40M | $149.30M | $171.70M | $78.40M |
Free Cash Flow OCF − CapEx | $114.00M | $133.90M | $196.00M | $79.70M |
Shares Outstanding | 139.74M | 144.80M | 146.86M | 146.70M |